RE/MAX (RMAX) and Hub Group (HUBG), Pediatrix Medical Group (MD), Texas Instruments (TXN) Shares Are Falling, What You Need To Know What Happened? A number of stocks fell in the pre-market session after President Trump announced "reciprocal tariffs" on all US imports, set at a minimum rate of 10%. Markets reacted negatively to the announcement, reflecting deep concerns among investors about the broader economic implications. The tariffs were likely seen as a significant threat to global trade flows, with the potential to slow economic growth, drive up consumer prices, and spark retaliatory measures. Wedbush analyst Dan Ives captured the prevailing market anxiety, stating, "We would characterize this slate of tariffs as 'worse than the worst case scenario' the Street was fearing." His comment highlighted how the scope and severity of the tariffs far exceeded Wall Street's expectations, adding a new layer of uncertainty for businesses and investors. The stock market overreacts to news, and big price drops can present good opportunities to buy high-quality stocks. Among others, following stocks were impacted: Real Estate Services company RE/MAX (NYSE:RMAX) fell 6.9%. Is now the time to buy RE/MAX? Access our full analysis report here, it’s free. Air Freight and Logistics company Hub Group (NASDAQ:HUBG) fell 12.2%. Is now the time to buy Hub Group? Access our full analysis report here, it’s free. Specialized Medical & Nursing Services company Pediatrix Medical Group (NYSE:MD) fell 6.7%. Is now the time to buy Pediatrix Medical Group? Access our full analysis report here, it’s free. Analog Semiconductors company Texas Instruments (NASDAQ:TXN) fell 7.5%. Is now the time to buy Texas Instruments? Access our full analysis report here, it’s free. Zooming In On Hub Group (HUBG) Hub Group’s shares are not very volatile and have only had 3 moves greater than 5% over the last year. Moves this big are rare for Hub Group and indicate this news significantly impacted the market’s perception of the business. Hub Group is down 23.3% since the beginning of the year, and at $33.86 per share, it is trading 36.4% below its 52-week high of $53.20 from November 2024. Investors who bought $1,000 worth of Hub Group’s shares 5 years ago would now be looking at an investment worth $1,555. Unless you’ve been living under a rock, it should be obvious by now that generative AI is going to have a huge impact on how large corporations do business. We prefer a lesser-known (but still profitable) semiconductor stock benefiting from the rise of AI. Click here to access our free report on our favorite semiconductor growth story. View Comments
RE/MAX (RMAX) and Hub Group (HUBG), Pediatrix Medical Group (MD), Texas Instruments (TXN) Shares Are Falling, What You Need To Know
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research.
Start Your Free Trial Now!Not sure where to invest today?
Kalkine’s latest research highlights three companies identified through in-depth analysis and market insights.
Explore these research reports to learn about companies currently being tracked by our analysts and make more informed investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...